comprehensive -WSS

comprehensive

author：explore 2025-09-30 15:15:41 - browse：6283

An advisory committee to the Food and Drug Administration will convene on Tuesday to evaluate the benefits of renal denervation, a one-time surgical procedure that works to reduce blood pressure. The promise — and the potential market — is enormous, but the data on how well the procedure works remains contentious.

The committee will evaluate data from two companies vying for market approval: ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and device giant Medtronic, both of which have made surgical systems to treat hypertension.

Data from an analysis of three randomized clinical trials of ReCor Medical’s device showed a modest decrease in blood pressure after two months compared to a control group that received a placebo procedure. Medtronic’s late-stage trial showed that renal denervation reduced hypertension when measuring blood pressure in the doctor’s office, but did not show a reduction in blood pressure when patients measured it at home over 24 hours. At-home blood pressure is considered the more accurate measure, as blood pressure levels tend to artificially rise with anxiety in the clinic. Neither study presented serious safety concerns.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Biden’s NIH nominee is languishing in Congress

entertainment

focus

WSS

Eisai exec who led development of Alzheimer’s drug to retire

Dog Aging Project founders on what lies ahead after losing funding

CVS is on a mission to consolidate health care. Will it work?

CVS is on a mission to consolidate health care. Will it work?

There's an unseen cost to disruptive road

Teachers share how revamped forgiveness program helped with their student loans

hotspot

comprehensive

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Biden’s NIH nominee is languishing in Congress

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

FDA sets aggressive timeline for overhauling inspection procedures

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Pumping milk in bathrooms at health conferences is common

DIEP, the 'gold standard' of breast reconstruction, is under threat

Create a giant ice tray with this foil pan hack to keep food cold this summer

Sports medicine is finally prioritizing gender equality

CVS is on a mission to consolidate health care. Will it work?

hotspot

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Pandemic and All Hazards Preparedness Act needs lean update

Dog Aging Project founders on what lies ahead after losing funding

There's an unseen cost to disruptive road

entertainment

focus

leisure time

explore